HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BI 6727

a polo-like kinase inhibitor with broad antitumor activity; structure in first source
Also Known As:
BI-6727; volasertib
Networked: 104 relevant articles (12 outcomes, 34 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Taube, Tillmann: 7 articles (05/2022 - 08/2014)
2. Ahmad, Nihal: 5 articles (02/2022 - 11/2014)
3. Pilz, Korinna: 5 articles (03/2016 - 04/2014)
4. Ndiaye, Mary A: 3 articles (02/2022 - 01/2017)
5. Singh, Chandra K: 3 articles (02/2022 - 01/2017)
6. Fiedler, Walter: 3 articles (08/2021 - 05/2014)
7. Peeters, Marc: 3 articles (11/2019 - 10/2015)
8. Specenier, Pol: 3 articles (11/2019 - 10/2015)
9. Fulda, Simone: 3 articles (01/2019 - 01/2016)
10. Rudolph, Dorothea: 3 articles (01/2018 - 05/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3. Lymphoma (Lymphomas)
4. Weight Loss (Weight Reduction)
5. Rhabdomyosarcoma

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. GSK 461364
3. Vincristine (Oncovin)
4. Integrins
5. Peptides (Polypeptides)
6. palbociclib
7. belinostat
8. BI 836858
9. BI 6727
10. Polo-Like Kinase 1

Related Therapies and Procedures

1. Molecular Targeted Therapy
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Therapeutics
5. Intravenous Infusions